Optimizing Testing and Selection of First-Line Therapy in NSCLC
This presentation reviews how to optimize testing and selection of first-line therapy in non-small cell lung cancer (NSCLC).
Date of Last Review: June 04, 2024
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice